Found 112 matching trials
A Study of Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment PHASE4 This study will evaluate the pharmacokinetics (area under the curve \[AUC\]...
Show More Location
Multiple Locations
Learn More & Join Trial
Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection PHASE3 This study was to assess whether sofosbuvir in combination with ribavirin (...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
Neutrino Regimen for Treatment-experienced HCV GT1 Patients PHASE4 This study will evaluate the efficacy and safety of NEUTRINO regimen in Chi...
Show More Location
Liver Fibrosis Diagnosis and Treatment Centre, 302 Hospital
Learn More & Join Trial
Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype PHASE3 The purpose of this study is to evaluate if a 12-week total regimen of tela...
Show More Location
Multiple Locations
Learn More & Join Trial
A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment PHASE3 The purpose of this study is to determine the safety, efficacy and tolerabi...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients PHASE2 The purpose of this study is to determine whether the use of an antidepress...
Show More Location
Fundacion Hospital Alcorcon
Learn More & Join Trial
An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation PHASE3 The purpose of this study is to evaluate the effectiveness of telaprevir in...
Show More Location
Multiple Locations
Learn More & Join Trial
Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3 PHASE4 The primary objective of the study is to demonstrate that the efficacy of p...
Show More Location
Göteborg University
Learn More & Join Trial
DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C) PHASE4 To examine the safety and efficacy of response guided triple therapy (PEG-I...
Show More Location
St Vincent's Hospital
Learn More & Join Trial
An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients PHASE2 To assess efficacy of telaprevir, pegylated interferon alfa-2a (Peg-IFN-alf...
Show More Learn More & Join Trial